Neonatal septicaemia remains a major problem in perinatology and paediatric infectious disease. In the past few years attention has been focussed on the growing role of group A complete list of bacterial pathogens is given in Table 1 . Although a total of 27 different bacteria were implicated as causative organisms, only three accounted for a major share in the aetiology: group B streptococcus 32%, Staphylococcus aureus 22%, and Escherichia coli 20%. All the remaining 24 bacteria accounted for one fourth of the total cases and these were taken as a fourth aetiologic group in the analyses, in the realisation that the group was very heterogeneous indeed. Ninety three patients died, making the overall mortality 23%.
The onset of symptoms and its relation to mortality of neonatal septicaemia is illustrated in Fig. 1 . Almost half the infants had symptoms occurring within the first 24 hours of life, which in many cases meant immediately after birth, and this group had the highest mortality (30%). Infants suffering septicaemia in the first day of life were clearly separable from the remainder and there was no apparent division line in incidence or mortality 1---% group.bmj.com on October 13, 2017 -Published by http://adc.bmj.com/ Downloaded from later ( Fig. 1) . We then divided the cases conventionally into those with symptoms occurring within the first week (early onset) or during the second to fourth weeks (late onset) of life (Table 2) .
In cases presenting within the first 24 hours of life, group B streptococcus was the major causative organism, with E coli second and S aureus third (Table 2 ). There were seven cases (4%) caused by listeria and in the remaining 40 cases a large number of bacteria were implicated. Septicaemia with onset in the first 24 hours carried a higher mortality than the later onset disease (30% v 17%, P<0-001), but mortality from very early onset disease was not dependent on the causative organism. In fact mortality attributable to each pathogen was directly proportional to the aetiologic importance of that pathogen; for example group B streptococcus was responsible for 52% of the deaths, which equalled 30% death rate, or exactly the same as in the total group ( Table 2) .
The aetiologic distribution in cases presenting during the first week but after the first 24 hours was different from that in the very early onset group, and the outcome was dependent on the causative organism ( Table 2) . Group B streptococcus infection accounted for only 14% of the cases with zero mortality. S aureus was the most common pathogen in this group, but was associated with a relatively low mortality. In contrast, E coli was responsible for only 24% of the cases but for 47% of the deaths in the group, equalling to 31% mortality.
The late onset group comprised only 10% of the cases (Table 2) . Mortality was 22-5%, which is actually the same as in all the cases with onset in the first week combined. There was one death from group B streptococcus infection, but this was the only fatality among 37 patients with onset after the first 24 hours.
The 'profiles' of the major individual pathogens in relation to onset of symptoms and mortality are presented in Fig. 2 . Group B streptococcus infections were characterised by the very early onset: 71-5% began within the first 24 hours and all but one of the deaths were in this group. Most E coli infections were also of early onset, but many were clustered around days two to four of life. Staph aureus infections occurred rather evenly throughout the neonatal period, and carried a lower mortality than group B streptococcus or E. coli.
There were 51 cases of meningitis (determined by positive cerebrospinal fluid culture). Mortality in these cases was 24%, that is the same as in the total group. The two most important pathogens were group B streptococcus and E coli, which accounted for 41% of the cases each. The outcome in these two groups was different, however: none of the 21 patients with group B streptococcus meningitis died, whereas E coli meningitis was associated with a 33% mortality.
Low birthweight was associated with high mortality from neonatal septicaemia (Table 3) and was thus another important determinant of poor prog- nosis in addition to early onset of symptoms. While the mortality of infants weighing 2500 g or more was only 10%, however, they still accounted for 28% of all deaths.
Altogether 43 blood culture isolates of group B streptococcus were available for serotyping and 41 were typable. The predominant serotypes were Ib or Ic, or both, with 28 (65%) isolates. There were no cases of type Ia, nine cases (21%) of type II, and four cases (9%) of type III. Three of the four isolates of serotype III were from cases with meningitis, but of early onset. Three isolates came from patients with late onset disease; two of them were of serotype I bc and one was not typable.
Discussion
The present survey confirms that neonatal septicaemia is a major problem in perinatology and paediatric infectious disease today in Finland. The survey also showed epidemiological features of neonatal septicaemia that may help direct future preventive measures. These findings were made because of the large study population which resolved any minor fluctuations and variations between hospitals which might have occurred.
The overall incidence of neonatal septicaemia in Finland, 3 per 1000 births, was of the same magnitude as that reported from Sweden for the years 1974-8, with the claim that the incidence in Sweden is increasing.9 10 We do not have any comparable figures for Finland from previous years, but within the five year study period there was no apparent trend towards an increase. It will be important, however, to continue surveillance of neonatal septicaemia to determine the trend.
Mortality from neonatal septicaemia in Finland was found to be relatively low for all the diagnosed cases combined, for all patients with group B streptococcus septicaemia, and for early and late onset disease separately. At the same time, how- 
